Get started
Author

Ana María Vázquez

Observed names: A. M. Vazquez, A. M. Vázquez, A. Vazquez, A.M. VÁZQUEZ, A.M. Vázquez, Ana M Vázquez, Ana M. H. Vázquez, Ana M. Vazquez, Ana M. Vázquez, Ana Maria Vazquez, Ana Maria Vázquez, Ana María Vázquez
Observed institutions: Universidad Católica de Córdoba, National University of Quilmes, Center of Molecular Immunology (Cuba), University of Havana, Centro de Ingeniería Genética y Biotecnología, Centro Nacional de Investigaciones Científicas, Université de Montréal
ORCID: 0000-0003-1265-5066
Observed ORCID: 0000-0003-1265-5066
OpenAlex ID: A5101936588
A Mouse IgG 1 Monoclonal Antibody Specific for N -Glycolyl GM3 Ganglioside Recognized Breast and Melanoma Tumors
2000 · Adriana Carr, Ailette Mullet, et al. · Hybridoma · 120
An Anti-Idiotype Vaccine Elicits a Specific Response to N-Glycolyl Sialic Acid Residues of Glycoconjugates in Melanoma Patients
2002 · Mauro Alfonso, Alain Díaz, et al. · The Journal of Immunology · 113
Generation of a Murine Monoclonal Antibody Specific for N -Glycolylneuraminic Acid-Containing Gangliosides That Also Recognizes Sulfated Glycolipids
1995 · A.M. VÁZQUEZ, M. ALFONSO, et al. · Hybridoma · 94
Characterization of the Antibody Response against NeuGcGM3 Ganglioside Elicited in Non-Small Cell Lung Cancer Patients Immunized with an Anti-Idiotype Antibody
2008 · Ana María Hernández, Darién Toledo, et al. · The Journal of Immunology · 91
PDF
Active immunotherapy with 1E10 anti-idiotype vaccine in patients with small cell lung cancer: Report of a phase I trial
2007 · Elia Neninger, R.M. Diaz, et al. · Cancer Biology & Therapy · 88
PDF
Clinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with 99mTc
2005 · Juan P. Oliva, Zodilina Valdés, et al. · Breast Cancer Research and Treatment · 67
Anti-NeuGcGM3 Antibodies, Actively Elicited by Idiotypic Vaccination in Nonsmall Cell Lung Cancer Patients, Induce Tumor Cell Death by an Oncosis-Like Mechanism
2011 · Ana María Hernández, Nely Rodríguez, et al. · The Journal of Immunology · 64
PDF
GM3(Neu5Gc) ganglioside: an evolution fixed neoantigen for cancer immunotherapy
2018 · Mayrel Labrada, Denise Dorvignit, et al. · Seminars in Oncology · 62
PDF
Cellular and Humoral Immune Response to N-Glycolyl-GM3 Elicited by Prolonged Immunotherapy With an Anti-Idiotypic Vaccine in High-Risk and Metastatic Breast Cancer Patients
2006 · Marcelo D. Guthmann, Mónica A. Castro, et al. · Journal of Immunotherapy · 60
Sedative effect of central administration of Coriandrum sativum essential oil and its major component linalool in neonatal chicks
2016 · María Soledad Gastón, Mariana Paula Cid, et al. · Pharmaceutical Biology · 54
PDF
Detection and Characterization of N-Glycolyated Gangliosides in Wilms Tumor by Immunohistochemistry
2009 · Alejandra M. Scursoni, Laura Galluzzo, et al. · Pediatric and Developmental Pathology · 44
Antiatherosclerotic Effect of an Antibody That Binds to Extracellular Matrix Glycosaminoglycans
2012 · Yosdel Soto, Emilio Acosta, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 41
In Vivo and In Vitro Anti-Tumor Effect of 14F7 Monoclonal Antibody
2002 · Adriana Carr, Circe Mesa, et al. · Hybridoma and Hybridomics · 39
Ganglioside-based vaccines and anti-idiotype antibodies for active immunotherapy against cancer
2003 · Luis E Fernández, Daniel F Alonso, et al. · Expert Review of Vaccines · 38
Delineation of the epitope recognized by an antibody specific for N-glycolylneuraminic acid--containing gangliosides
1998 · E. Moreno, B. Lanne, et al. · Glycobiology · 38
Metronomic Cyclophosphamide and Methotrexate Chemotherapy Combined with 1E10 Anti-Idiotype Vaccine in Metastatic Breast Cancer
2011 · Jorge L. Soriano, Noyde Batista, et al. · International Journal of Breast Cancer · 37
PDF
Generation of anti-Neu-glycolyl-ganglioside antibodies by immunization with an anti-idiotype monoclonal antibody: A self versus non-self-matter
2005 · Ana María Hernández, Mabel Rodríguez, et al. · Immunobiology · 36
Induction of Anti-Anti-Idiotype Antibodies Against Sulfated Glycosaminoglycans Reduces Atherosclerosis in Apolipoprotein E–Deficient Mice
2012 · Víctor Brito, Katia Mellal, et al. · Arteriosclerosis Thrombosis and Vascular Biology · 35
Combined therapeutic effect of a monoclonal anti-idiotype tumor vaccine against NeuGc-containing gangliosides with chemotherapy in a breast carcinoma model
2009 · D. Fuentes, J. Avellanet, et al. · Breast Cancer Research and Treatment · 33
Anti-ganglioside anti-idiotypic monoclonal antibody-based cancer vaccine induces apoptosis and antiangiogenic effect in a metastatic lung carcinoma
2008 · Y. Diaz, A. Gonzalez, et al. · Cancer Immunology Immunotherapy · 28
Immunogenetic Analysis of Variable Regions Encoding AB1 and γ -Type AB2 Antibodies from the NeuGc-Containing Ganglioside Family
2001 · Alexis Perez, Josefa Lombardero, et al. · Hybridoma · 27
Switching on cytotoxicity by a single mutation at the heavy chain variable region of an anti-ganglioside antibody
2011 · Yuniel Fernández-Marrero, Tays Hernández, et al. · Molecular Immunology · 26
Gangliosides, Ab1 and Ab2 antibodies
2006 · Alejandro López-Requena, Cristina Mateo De Acosta, et al. · Molecular Immunology · 24
Arresting progressive atherosclerosis by immunization with an anti-glycosaminoglycan monoclonal antibody in apolipoprotein E-deficient mice
2015 · Livan Delgado-Roche, Víctor Brito, et al. · Free Radical Biology and Medicine · 22
Preclinical evaluation of racotumomab, an anti-idiotype monoclonal antibody to N-glycolyl-containing gangliosides, with or without chemotherapy in a mouse model of non-small cell lung cancer
2012 · Valeria I. Segatori, Ana M. Vazquez, et al. · Frontiers in Oncology · 22
PDF
Works count: 70
Citation count: 1,550
H-index: 23
I10-index: 39
Year
Topic
Type